Evidence map›Paper›PMID 37047092›Full record

ReviewInternational journal of molecular sciences2023

Ginsenosides from

Won Young Jang, Ji Yeon Hwang, Jae Youl Cho

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 75 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Journal of ginseng research · 2026
    Review
  5. Article
  6. Article
  7. Molecular pharmaceutics · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Avicenna journal of phytomedicine · 2026
    Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Won Young JangDepartment of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Republic of Korea.ORCID 0000-0001-8818-7698
Ji Yeon HwangDepartment of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Jae Youl ChoDepartment of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Republic of Korea.ORCID 0000-0001-8141-9927
Sungkyunkwan University · KR

Funding

National Research Foundation of Korea 2017R1A6A1A03015642
6 · The paper itself

Abstract

Nuclear factor kappa B (NF-κB) signaling pathways progress inflammation and immune cell differentiation in the host immune response; however, the uncontrollable stimulation of NF-κB signaling is responsible for several inflammatory illnesses regardless of whether the conditions are acute or chronic. Innate immune cells, such as macrophages, microglia, and Kupffer cells, secrete pro-inflammatory cytokines, such as TNF-α, IL-6, and IL-1β, via the activation of NF-κB subunits, which may lead to the damage of normal cells, including neurons, cardiomyocytes, hepatocytes, and alveolar cells. This results in the occurrence of neurodegenerative disorders, cardiac infarction, or liver injury, which may eventually lead to systemic inflammation or cancer. Recently, ginsenosides from

Indexed as

Antineoplastic AgentsGinsenosidesPanaxAnti-Inflammatory AgentsInflammationNF-kappa BSignal TransductionAnti-Inflammatory AgentsAntineoplastic AgentsGinsenosidesNF-kappa Bcancerginsenosidesinflammatory illnessesNF-κBPanax ginseng

Identifiers

PMID37047092
PMCPMC10093821
OpenAlexW4360859334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.